Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can take a break from Mounjaro, and many people do — but how you pause, for how long, and what happens next matters more than most realise. Mounjaro (tirzepatide) is a prescription-only medicine, so any planned break should be discussed with your prescriber first. Here is what the evidence and clinical guidance actually say about stepping away from treatment, and what to expect when you do.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you're reading this, you're probably weighing something up: a holiday, a procedure, a patch of nausea that hasn't let up, or just a quiet worry about what this medicine is doing to your body long term. That's a completely reasonable thing to sit with. Mounjaro is not a supplement you dip in and out of casually, it's a dual GIP and GLP-1 receptor agonist that works by actively changing how your brain and gut register hunger and fullness. The moment you stop injecting, that effect begins to fade.
The NHS medicines guidance on tirzepatide is clear that treatment is intended to run alongside sustained lifestyle changes, not as a short course. That doesn't mean breaks are impossible; it means they carry real consequences worth knowing about before you decide.
Practically speaking, the first thing most people notice after stopping is that appetite comes back, sometimes gradually over a couple of weeks, sometimes faster. Gastric emptying speeds up again, portion sizes feel less naturally limited, and food noise (the background thoughts about eating that many describe as quietening on treatment) tends to return. If you want a fuller picture of what taking a break from Mounjaro actually involves day to day, that page walks through what patients commonly experience. None of that is a crisis, but it is worth factoring into any plan.
There are situations where pausing Mounjaro is not just reasonable but actively recommended by clinical guidance. Planned surgery is one: NHS England advises telling your anaesthetist and surgical team that you take a GLP-1 or tirzepatide medicine before any procedure, and some teams ask patients to pause for a set period beforehand because of the effect on gastric emptying. Your surgical team will give a specific instruction; follow that, not a general rule of thumb.
Pregnancy planning is another. Mounjaro is not recommended during pregnancy, breastfeeding or when actively trying to conceive. The MHRA advises using contraception throughout treatment; women using oral contraceptives should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because pill absorption can be affected. If your circumstances change in this direction, speak to your prescriber promptly.
Persistent or severe side effects (particularly significant nausea, vomiting or any symptoms that could suggest pancreatitis (severe stomach pain spreading to the back, with or without vomiting)) also warrant an urgent conversation rather than a self-managed stop. You can find guidance on managing common side effects in our frequently asked questions.
This is the part that catches people out. The SURMOUNT clinical programme, involving thousands of adults across its trials, showed that tirzepatide produces substantial average weight loss, around 20–21% of body weight at the highest dose over 72 weeks, as published in the New England Journal of Medicine. What the extension data make equally clear is that much of that loss is not permanently locked in once you stop. Weight regain after discontinuation is well documented across the GLP-1 and dual-agonist class.
That doesn't make the medicine pointless, far from it. It means the conversation about how long to stay on treatment, and what a responsible pause looks like, is one worth having with your prescriber rather than making quietly on your own. Some people pause for a short defined period and restart without much difficulty; if you're considering something short-term, our page on whether you can you have a break on Mounjaro covers the practical factors to weigh up. Others find that a break of more than a few weeks leads to meaningful weight regain that takes months to recover. Individual variation is real.
For context on how treatment costs factor into decisions about staying on or pausing, our Mounjaro cost page explains what is included in a private prescription at different stages of treatment.
If you've been off Mounjaro for more than four weeks, most prescribers will want to step the dose back down rather than resume at the dose you stopped at. This isn't a punishment for taking a break, it's straightforward pharmacology. Your tolerance to the GI effects resets during a gap, and picking up at 10mg or 12.5mg after a month off is likely to cause more nausea than when you were climbing the schedule the first time. For a closer look at the specifics of a shorter gap, our guide to a 2 week break from Mounjaro explains what typically happens to appetite and weight during that window and what restarting looks like afterwards.
A clinical review before restarting is standard practice at a regulated service. At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before anything is dispensed, no automatic renewals, no assumption that what suited you three months ago still suits you now. That review is also the moment to discuss what the break was for, whether anything has changed medically, and what a sensible restarting schedule looks like for your specific situation.
If you're weighing up whether to pause, our page on whether you can take a break from Mounjaro sets out the key clinical considerations alongside the practical ones, or our free consultation connects you with a prescriber who can look at the full picture, not just the question in isolation. There is no obligation, and the conversation is the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.